1. Stocks
    2. /
  2. Sirtex Medical Limited (ASX: SRX)
    3. /

Sirtex Medical Limited (ASX: SRX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Sirtex Medical Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

See The 5 Stocks

*Returns as of August 16th 2021

Sirtex Medical Limited (ASX: SRX)
Latest News

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
26 Sep 2017 $0.3000 0.00% Final 18 Oct 2017
27 Sep 2016 $0.3000 77.67% Final 19 Oct 2016
28 Sep 2015 $0.2000 100.00% 21 Oct 2015
03 Oct 2014 $0.1400 100.00% 22 Oct 2014
26 Sep 2011 $0.0700 100.00% Final 21 Oct 2011
24 Sep 2010 $0.0700 100.00% Final 14 Oct 2010
24 Nov 2009 $0.0500 100.00% Special Cash 15 Dec 2009
24 Nov 2009 $0.0200 100.00% Final 15 Dec 2009

SRX ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Sirtex Medical Limited

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Dr Katherine Leslie Woodthorpe Non-Executive Director Sep 2015
Dr Woodthorpe was the Chief Executive of AVCAL, the Australian Private Equity and Venture Capital Association for seven years. She has a deep knowledge of the private equity and the superannuation industry in the financial sector and a strong track record in a broad range of technology orientated industries. She is Chairman of the Risk, Health and Safety Committee.
Mr Andrew McLean Chief Executive OfficerManaging Director Jun 2017
Mr McLean has over 20 years of experience with a track record of success in regional and global leadership roles. Mr McLean's most recent roles were CEO, Applied Sterilisation Technologies and Laboratories with Synergy Health plc, and with STERIS Corporation.
Mr Neville Mitchell Non-Executive Director Apr 2017
Mr Mitchell has over 25 years of experience as a Chief Financial Officer at Cochlear Limited. During that time, Mr Mitchell was responsible for all financial aspects of the business, including ASX compliance and governance, banking, acquisitions and mergers, together with forecasting/budgetary management, legal and company secretarial. He is a member of the Risk, Health and Safety Committee.
Mr Darren Smith Chief Financial OfficerCompany Secretary Jul 2008
-
Darren Smith Chief Financial OfficerCompany Secretary
-
Kevin Smith Executive Vice President Sales and Marketing Americas
-
Anthony Dixon Executive Vice President Sales and Marketing EMEA
-
G Spindler Global Head of Operations
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 21,540,824 38.62%
Citicorp Nominees Pty Limited 8,814,905 15.80%
J P Morgan Nominees Australia Limited 4,604,340 8.26%
BNP Paribas Nominees Pty Ltd (Agency Lending DRP A/C) 3,678,000 6.59%
National Nominees Limited 2,571,733 4.61%
Cs Third Nominees Pty Limited (HSBC Cust Nom Au Ltd 13 A/C) 1,369,825 2.46%
Bannaby Investments Pty Limited (Bannaby Super Fund A/C) 610,000 1.09%
National Nominees Limited (N A/C) 568,000 1.02%
Merrill Lynch (Australia) Nominees Pty Ltd 429,383 0.77%
Mr Tod Mcgrouther 425,921 0.76%
Bnp Paribas Nominees Pty Ltd [Agency Lending DRP A/C] 418,854 0.75%
Ifm Pty Limited [Ifm Super Fund A/C] 358,570 0.64%
Bnp Paribas Nominees Pty Ltd [DRP] 297,715 0.53%
Amp Life Limited 202,793 0.36%
Arrakis Nominees Pty Ltd [Arrakis Family Capital A/C] 167,835 0.30%
Attunga Nominees Pty Ltd 130,000 0.23%
Warbont Nominees Pty Limited [Unpaid Entrepot A/C] 123,961 0.22%
Easn Pty Ltd [Penance A/C] 120,000 0.22%
Mr Keith Kerridge 100,555 0.18%
Bnp Paribas Nominees Pty Ltd [Ib Au Noms Retailclient DRP] 97,761 0.18%

Profile

since

Note